The Director of France's National Sickness Insurance Funds (CNAM), Frederic van Roekeghem, has confirmed a fall of 1.8% in the reimbursement of drugs in the first quarter of this year, compared with the like-period of 2007. Speaking to the daily La Tribune, the CNAM's Director explained that "it is probable that the French have adopted a more parsimonious management of their household pharmacy supplies: they first check that they don't have a given medicine before acquiring more of it."
The "franchise effect" is considered to have reduced drug wastage and over-stocking. For prescription drugs, a levy of 0.50 euros ($0.77) per item is collected, with a yearly maximum per patient of 50 euros for all fees.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Sign up to receive email updates
Join industry leaders for a daily roundup of biotech & pharma news
Copyright © The Pharma Letter 2025 | Headless Content Management with Blaze